[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
December 28, 2005

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial—Correction

JAMA. 2005;294(24):3092. doi:10.1001/jama.294.24.3092

Author Contribution Omissions: In the Original Contribution entitled “High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial” published in the November 16, 2005, issue of JAMA (2005;294:2437-2445), several contributions were omitted for the author Anders G. Olsson, MD, PhD. In addition to his contributions listed in the article, Dr Olsson contributed to the study concept and design, acquisition of data, drafting of the manuscript, and statistical analysis for the IDEAL trial.

×